Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy

BACKGROUND: Duchenne muscular dystrophy (DMD) cardiomyopathy is a progressive disease for which there is no cure. Disease-specific therapies are needed that can be initiated before irreversible myocardial damage ensues. In order to evaluate therapeutic efficacy, surrogate endpoints other than ejecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Soslow, Jonathan H., Damon, Stephen M., Crum, Kimberly, Lawson, Mark A., Slaughter, James C., Xu, Meng, Arai, Andrew E., Sawyer, Douglas B., Parra, David A., Damon, Bruce M., Markham, Larry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722665/
https://www.ncbi.nlm.nih.gov/pubmed/26795569
http://dx.doi.org/10.1186/s12968-016-0224-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722665/
https://www.ncbi.nlm.nih.gov/pubmed/26795569
http://dx.doi.org/10.1186/s12968-016-0224-7

Ejemplares similares